Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.68
+0.22 (3.41%)
Aug 18, 2026, 1:03 PM EDT - Market open

Journey Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.1-11.43-14.67-3.85-29.63-43.99
Depreciation & Amortization
4.324.353.523.774.372.56
Other Amortization
0.440.470.310.360.062.57
Asset Writedown & Restructuring Costs
---3.14-13.82
Stock-Based Compensation
6.066.296.12.614.432.47
Provision & Write-off of Bad Debts
0.05-0.210.520.440.280.05
Other Operating Activities
---1.130.440.775.64
Change in Accounts Receivable
-20.66-19.344.4812.55-5.380.77
Change in Inventory
4.74.81-4.233.951.74-8.46
Change in Accounts Payable
-4.71-7.2-2.1-18.4214.3420.39
Change in Income Taxes
-0.070.010.010.020.03-0.09
Change in Other Net Operating Assets
8.499.82-1.920.24-4.552.1
Operating Cash Flow
-7.49-12.44-9.135.24-13.53-2.18
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Sale (Purchase) of Intangibles
---15-5-20-10
Investing Cash Flow
---15-5-20-10

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---2857
Long-Term Debt Issued
--101519.769.54
Total Debt Issued
--104324.7616.54
Short-Term Debt Repaid
----30.95-2.86-6.19
Long-Term Debt Repaid
--0.63-1.25-21-5-5.3
Total Debt Repaid
--0.63-1.25-51.95-7.86-11.49
Net Debt Issued (Repaid)
--0.638.75-8.9516.95.05
Issuance of Common Stock
12.9216.938.294.620.1432.54
Other Financing Activities
-0.08-0.08-0.05-0.47-0.59-3.55
Financing Cash Flow
12.8416.2316.99-4.816.4653.02

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
5.353.79-7.13-4.56-17.0840.84

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7.49-12.44-9.135.24-13.53-2.18
Free Cash Flow Growth
------
Free Cash Flow Margin
-10.99%-20.11%-16.26%6.62%-18.37%-3.45%
Free Cash Flow Per Share
-0.28-0.51-0.450.29-0.77-0.21
Levered Free Cash Flow
-5.46-8.35-18.48-4.79-24.51-4.25
Unlevered Free Cash Flow
-3.61-6.51-17.1-4.09-23.31-2.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.233.242.011.130.99-
Cash Income Tax Paid
0.090.050.130.180.170.16
Change in Working Capital
-12.25-11.9-3.77-1.666.1914.71
SEC Filings: 10-K · 10-Q